Synapse

← BMC Clinical Pharmacology

Papers in BMC Clinical Pharmacology

Page 1 · newest first

  1. Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian populationBMC Clinical Pharmacology · 2012
  2. Errors in medication history at hospital admission: prevalence and predicting factorsBMC Clinical Pharmacology · 2012
  3. Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trialBMC Clinical Pharmacology · 2012
  4. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in NigeriaBMC Clinical Pharmacology · 2012
  5. A cost effectiveness analysis of the preferred antidotes for acute paracetamol poisoning patients in Sri LankaBMC Clinical Pharmacology · 2012
  6. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvementENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2012
  7. Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjectsBMC Clinical Pharmacology · 2012
  8. Mechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocolBMC Clinical Pharmacology · 2012
  9. Effects of paliperidone extended release on the symptoms and functioning of schizophreniaBMC Clinical Pharmacology · 2012
  10. The association between drospirenone and hyperkalemia: a comparative-safety studyBMC Clinical Pharmacology · 2011
  11. Etomidate and mortality in cirrhotic patients with septic shockBMC Clinical Pharmacology · 2011
  12. Price, familiarity, and availability determine the choice of drug - a population-based survey five years after generic substitution was introduced in FinlandBMC Clinical Pharmacology · 2011
  13. Use of antipsychotic and antidepressant within the Psychiatric Disease Centre, Regional Health Service of FerraraBMC Clinical Pharmacology · 2011
  14. Public perception on the role of community pharmacists in self-medication and self-care in Hong KongBMC Clinical Pharmacology · 2011
  15. Knowledge, attitudes and practice survey about antimicrobial resistance and prescribing among physicians in a hospital setting in Lima, PeruBMC Clinical Pharmacology · 2011
  16. Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysisBMC Clinical Pharmacology · 2011
  17. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlatesBMC Clinical Pharmacology · 2011
  18. Association between statin therapy and outcomes in critically ill patients: a nested cohort studyBMC Clinical Pharmacology · 2011
  19. An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltrationBMC Clinical Pharmacology · 2011
  20. The effects of polyunsaturated fatty acids in alcohol dependence treatment - a double-blind, placebo-controlled pilot studyBMC Clinical Pharmacology · 2011
  21. Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohortsBMC Clinical Pharmacology · 2011
  22. No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled studyBMC Clinical Pharmacology · 2011
  23. The future of pharmaceutical care in France: a survey of final-year pharmacy students' opinionsBMC Clinical Pharmacology · 2011
  24. Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance databaseBMC Clinical Pharmacology · 2011
  25. Use, tolerability and compliance of spironolactone in the treatment of heart failureBMC Clinical Pharmacology · 2011
  26. Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studiesBMC Clinical Pharmacology · 2011
  27. Constipation and diarrhoea - common adverse drug reactions? A cross sectional study in the general populationBMC Clinical Pharmacology · 2011
  28. Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancerBMC Clinical Pharmacology · 2011
  29. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008BMC Clinical Pharmacology · 2010
  30. The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finlandBMC Clinical Pharmacology · 2010
  31. Comparison of the pharmacokinetics, safety and tolerability of two concentrations of a new liquid recombinant human growth hormone formulation versus the freeze-dried formulationBMC Clinical Pharmacology · 2010
  32. Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha1-antitrypsin deficiency: a randomized studyBMC Clinical Pharmacology · 2010
  33. Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trialsBMC Clinical Pharmacology · 2010
  34. Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West AfricaBMC Clinical Pharmacology · 2010
  35. The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamolBMC Clinical Pharmacology · 2010
  36. Traumeel S® for pain relief following hallux valgus surgery: a randomized controlled trialBMC Clinical Pharmacology · 2010
  37. Assessing Safety Culture in Pharmacies: The psychometric validation of the Safety Attitudes Questionnaire (SAQ) in a national sample of community pharmacies in SwedenBMC Clinical Pharmacology · 2010
  38. EVITA: a tool for the early EValuation of pharmaceutical Innovations with regard to Therapeutic AdvantageBMC Clinical Pharmacology · 2010
  39. Characteristics of primary health care units with focus on drug information from the pharmaceutical industry and adherence to prescribing objectives: a cross-sectional studyBMC Clinical Pharmacology · 2010
  40. Reporting randomised clinical trials of analgesics after traumatic or orthopaedic surgery is inadequate: a systematic reviewBMC Clinical Pharmacology · 2010
  41. Quantitative relationship between the octanol/water partition coefficient and the diffusion limitation of the exchange between adipose and bloodBMC Clinical Pharmacology · 2010
  42. Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteersBMC Clinical Pharmacology · 2009
  43. In vivo administration of BL-3050: highly stable engineered PON1-HDL complexesBMC Clinical Pharmacology · 2009
  44. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical resultsBMC Clinical Pharmacology · 2009
  45. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, NigeriaBMC Clinical Pharmacology · 2009
  46. A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusionBMC Clinical Pharmacology · 2009
  47. Dispensed drugs and multiple medications in the Swedish population: an individual-based register studyBMC Clinical Pharmacology · 2009
  48. Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trialBMC Clinical Pharmacology · 2009
  49. Errors and omissions in hospital prescriptions: a survey of prescription writing in a hospitalBMC Clinical Pharmacology · 2009
  50. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialtyBMC Clinical Pharmacology · 2009